Skip to main content
SpringerLink
Log in
Book cover

Histiocytic Disorders pp 339–360Cite as

Rosai–Dorfman Disease

  • Chapter
  • First Online:

Abstract

Rosai–Dorfman disease (RDD) is a benign non-Langerhans cell histiocytic disorder that usually presents with massive lymphadenopathy and sinus histiocytosis, although at least 40% of patients can have extranodal involvement. Recent studies found NRAS, KRAS, and ARAF mutations in a subset of patients with RDD, but no BRAF-V600E mutations have been reported yet. RDD is often associated with autoimmune or malignant disease, and rare cases of hereditary RDD have been reported as well. In most cases, RDD is self-limited and observation is the standard approach. However, 7–12% of patients die from the disease. Treatment is restricted to patients with life-threatening, multiple-relapsing, or autoimmune-associated disease.

This is a preview of subscription content, log in via an institution.

References

  1. Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy. Arch Pathol. 1969;87(1):63–70.

    CAS  PubMed  Google Scholar 

  2. Destombes P. Ade’nites avec surcharge lipidique, de l’enfant ou de l’adulte jeune, observe’es aux Antilles et au Mali. Bull Soc Pathol Exot. 1965;58(6):1169–75.

    CAS  Google Scholar 

  3. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity. Semin Diagn Pathol. 1990;7(1):19–73.

    CAS  PubMed  Google Scholar 

  4. Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mahzoni P, Zavareh MHT, Bagheri M, Neda Hani N, Moqtader B. Intracranial ROSAI-DORFMAN disease. J Res Med Sci. 2012;17(3):304–7.

    PubMed  PubMed Central  Google Scholar 

  6. Warrier R, Chauhan A, Jewan Y, Bansal S, Craver R. Rosai-Dorfman disease with central nervous system involvement. Clin Adv Hematol Oncol. 2012;10(3):196–8.

    PubMed  Google Scholar 

  7. Kutlubay Z, Bairamov O, Sevim A, Demirkesen C, Mat MC. Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature. Am J Dermatopathol. 2013;36:1–5.

    Google Scholar 

  8. Paulli M, Bergamaschi G, Tonon L, et al. Evidence for a polyclonal nature of the cell infiltrate in sinus histiocytosis with massive lymphadenopathy (rosai-dorfman disease). Br J Haematol. 1195;91(2):415–8.

    Article  Google Scholar 

  9. Dalia S, Sagatys E, Sokol L, Kubal T. Rosai-Dorfman disease: tumor biology, clinical features, pathology, and treatment. Cancer Control. 2014;21(4):322–7.

    Article  PubMed  Google Scholar 

  10. Delacretaz F, Meuge-Moraw C, Anwar D, Borisch B, Chave JP. Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease) in an HIV-positive patient. Virchows Arch A Pathol Anat Histopathol. 1991;419(3):251–4.

    Article  CAS  PubMed  Google Scholar 

  11. di Dio F, Mariotti I, Coccolini E, Bruzzi P, Predieri B, Lughetti L. Unusual presentation of Rosai-Dorfman disease in a 14-month-old Italian child: a case report and review of the literature. BMC Pediatr. 2016;16:62. doi:10.1186/s12887-016-0595-9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer. 2014;61(7):1329–35.

    Article  PubMed  Google Scholar 

  13. Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol. 2005;29(7):903–11.

    Article  PubMed  Google Scholar 

  14. Lu D, Estalilla OC, Manning JT Jr, Medeiros LJ. Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature. Mod Pathol. 2000;13(4):414–9.

    Article  CAS  PubMed  Google Scholar 

  15. Long E, Lassalle S, Cheikh-Rouhou R, Hofman V, Lacour JP, Hofman P. Intestinal occlusion caused by Rosai-Dorfman disease mimicking colonic diverticulitis. Pathol Res Pract. 2007;203:233–7.

    Article  PubMed  Google Scholar 

  16. Ambati S, Chamyan G, Restrepo R, et al. Rosai-Dorfman disease following bone marrow transplantation for pre-B cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51(3):433–5.

    Article  CAS  PubMed  Google Scholar 

  17. O'Malley DP, Duong A, Barry TS, et al. Co-occurrence of Langerhans cell histiocytosis and Rosai-Dorfman disease: possible relationship of two histiocytic disorders in rare cases. Mod Pathol. 2010;23:1616–23.

    Article  PubMed  Google Scholar 

  18. Cohen-Aubart F, Haroche J, De Risi T, et al. La maladie de Rosai–Dorfman-Destombes est une histiocytose inflammatoire polymorphe: etude phenotypique multicentrique de 47 patients. Orale Communication at the 71st Congress of the Socie’te´ Nationale Franc¸aise de Medecine Interne (SNFMI). June 10–12, 2015. Besancon.

    Google Scholar 

  19. Chakraborty R, Hampton OA, Shen X, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014;124(19):3007–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6(2):154–65.

    Article  CAS  PubMed  Google Scholar 

  21. Zhao M, Li C, Zheng J, et al. Extranodal Rosai-Dorfman disease involving appendix and mesenteric nodes with protracted course: a report of a rare case lacking relationship to IgG4-related disease and review of the literature. Int J Clin Exp Pathol. 2013;6(11):2569–77.

    PubMed  PubMed Central  Google Scholar 

  22. Wimmer DB, Ro JY, Lewis A, et al. Extranodal Rosai-Dorfman disease associated with increased numbers of immunoglobulin g4 plasma cells involving the colon: case report with literature review. Arch Pathol Lab Med. 2013;137(7):999–1004.

    Article  PubMed  Google Scholar 

  23. Liu L, Perry AM, Cao W, et al. Relationship between Rosai-Dorfman disease and IgG4-related disease: study of 32 cases. Am J Clin Pathol. 2013;140(3):395–402.

    Article  PubMed  Google Scholar 

  24. Menon MP, Evbuomwan MO, Rosai J, Jaffe ES, Pittaluga S. A subset of Rosai-Dorfman disease cases show increased IgG4-positive plasma cells: another red herring or a true association with IgG4-related disease? Histopathology. 2014;64(3):455–9.

    Article  PubMed  Google Scholar 

  25. Iwabuchi H, Kakihara T, Tanaka A, Uchiyama M, Shibuya H, Umezu H. Congenital Rosai-Dorfman disease without lymphadenopathy. Pediatr Pathol Mol Med. 2003;22:399–403.

    Article  PubMed  Google Scholar 

  26. Chow CP, Ho HK, Chan GCF, Cheung AN, Ha SY. Congenital Rosai-Dorfman disease presenting with anemia, thrombocytopenia and hepatomegaly. Pediatr Blood Cancer. 2009;52:415–7.

    Article  CAS  PubMed  Google Scholar 

  27. Morgan NV, Morris MR, Cangul H, Gleeson D, Straatman-Iwanowska A, Davies N, et al. Mutations in SLC29A3, encoding an equilibrative nucleoside transporter ENT3, cause a familial histiocytosis syndrome (Faisalabad histiocytosis) and familial Rosai-Dorfman disease. PLoS Genet. 2010;6(2):e1000833.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Avitan-Hersh E, Mandel H, Indelman M, et al. A case of H syndrome showing immunophenotype similarities to Rosai–Dorfman disease. Am J Dermatopathol. 2011;33(1):47–51.

    Article  PubMed  Google Scholar 

  29. Colmenero I, Molho-Pessach V, Torrelo A, Zlotogorski A, Requena L. Emperipolesis: an additional common histopathologic finding in H syndrome and Rosai-Dorfman disease. Am J Dermatopathol. 2012;34(3):315–20.

    Article  PubMed  Google Scholar 

  30. Rossbach HC, Dalence C, Wynn T, Tebbi C. Faisalabad histiocytosis mimics Rosai–Dorfman disease: brothers with lymphadenopathy, intrauterine fractures, short stature and sensorineural deafness. Pediatr Blood Cancer. 2006;47(5):629–32.

    Article  PubMed  Google Scholar 

  31. Jaffe R. Histiocytic proliferations in childhood. In: Proytcheva M, editor. Diagnostic pediatric hematopathology. Illinois: Feinberg School of Medicine, Northwestern University, Cambridge University Press; 2011. p. 504–39.

    Chapter  Google Scholar 

  32. Picarsic J, Chikwava K. In: Hsi ED, editor. Disorders of histiocytes hematopathology. 3rd ed. Philadelphia: Elsevier Saunders; 2017. (in press).

    Google Scholar 

  33. Picarsic J, Jaffe R. Nosology and pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015;29(5):799–823.

    Article  PubMed  Google Scholar 

  34. Utikal J, Ugurel S, Kurzen H, et al. Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses. Arch Dermatol. 2007;143:736–40.

    Article  CAS  PubMed  Google Scholar 

  35. Sodhi KS, Suri S, Nijhawan R, Kang M, Gautam V. Rosai-Dorfman disease: unusual cause of diffuse and massive retroperitoneal lymphadenopathy. Br J Radiol. 2005;78(933):845–7.

    Article  CAS  PubMed  Google Scholar 

  36. Litzner BR, Subtil A, Vidal CI. Combined cutaneous Rosai-Dorfman disease and localized cutaneous Langerhans cell histiocytosis within a single subcutaneous nodule. Am J Dermatopathol. 2015;37(12):936–9.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kuo TT, Chen TC, Lee LY, Lu PH. IgG4-positive plasma cells in cutaneous Rosai-Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4-related sclerosing disease. J Cutan Pathol. 2009;36(10):1069–73.

    Article  PubMed  Google Scholar 

  38. Al-Khateeb TH. Cutaneous Rosai-Dorfman disease of the face: a comprehensive literature review and case report. J Oral Maxillofac Surg. 2016;74:528–40.

    Article  PubMed  Google Scholar 

  39. Varan A, Sen H, Akalan N, et al. Pontine Rosai-Dorfman disease in a child. Child Nerv Syst. 2015;31:971–5.

    Article  Google Scholar 

  40. Ludemann W, Banan R, Samii A, et al. Cerebral Rosai-Dorfman disease. Child Nerv Syst. 2015;31:529–32.

    Article  Google Scholar 

  41. Gupta K, Bagdi N, Sunitha P, et al. Isolated intracranial Rosai-Dorfman disease mimicking meningioma in a child: a case report and review of the literature. Br J Radiol. 2011;84:e138–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Raslan O, Ketonen LM, Fuller GN, Schellingerhout D. Intracranial Rosai-Dorfman disease with relapsing spinal lesions. J Clin Oncol. 2008;26:3087–9.

    Article  PubMed  Google Scholar 

  43. Zhu H, Qiu LH, Dou YE, et al. Imaging characteristics of Rosai-Dorfman disease in the central nervous system. Eur J Radiol. 2012;81:1265–72.

    Article  PubMed  Google Scholar 

  44. Morandi X, Godey B, Riffaud L, et al. Isolated Rosai-Dorfman disease of the fourth ventricle. Case illustration. J Neurosurg. 2000;92:890.

    Article  CAS  PubMed  Google Scholar 

  45. Konishi E, Ibayashi N, Yamamoto S, Scheithauer BW. Isolated intracranial Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Am J Neuroradiol. 2003;24:515–8.

    PubMed  Google Scholar 

  46. Andriko JAW, Morrison A, Colegial CH, Davis BJ, Jones RV. Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases. Mod Pathol. 2001;14:172–8.

    Article  CAS  PubMed  Google Scholar 

  47. Ramos AA, Vega MAA, Alles JVD, Garcia JA, Martinez AM. Multiple involvement of the central nervous system in Rosai-Dorfman disease. Pediatr Neurol. 2012;46:54–6.

    Article  Google Scholar 

  48. Petzold A, Thom M, Powell M, Plant GT. Relapsing intracranial Rosai-Dorfman disease. J Neurol Neurosurg Psychiatry. 2001;71:538–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Md T, Khair A, Begum F, Akhter S, Farooq S, Kamal M. Isolated intracranial Rosai-Dorfman disease. Case Reports in Neuro Med. 2016;1972594:4.

    Google Scholar 

  50. Tran HM, Chinichian S, Storkersen K, Tokuhara K. An unusual case of extranodal Rosai-Dorfman disease manifesting as an Epibulbar mass. Case Rep Ophthalmol. 2015;6:351–5.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Nalini A, Jitender S, Anantaram G, Santosh V. Rosai-Dorfman disease: case with extensive dural involvement and cerebrospinal fluid pleocytosis. J Neurol Sci. 2012;314:152–4.

    Article  PubMed  Google Scholar 

  52. Yetsir S, Cekin E, Tosun F, Yildrim A. Rosai-Dorfman disease associated with neurosensorial hearing loss in two siblings. Int J Pediatr Otorino. 2004;68:1095–100.

    Article  Google Scholar 

  53. Ahsan SF, Madgy DN, Poulik J. Otolaryngologic manifestations of Rosai-Dorfman disease. Int J Pediatr Otorino. 2001;59:221–7.

    Article  CAS  Google Scholar 

  54. Kozak B, Talbott J, Uzelac A, Rehani B. Rosai-Dorfman disease isolated to the thoracic epidural spine. Radiol Case. 2015;9:6–16.

    Google Scholar 

  55. Chen CW, Kachramanoglou C, Revesz T, Choi D. Rosai-Dorfman disease presenting as a thoracic intradural extramedullary spinal tumor but without extraspinal manifestations. Acta Neurochir (Wein). 2012;154:367–8.

    Article  Google Scholar 

  56. Chen HH, Zhou SH, Wang SQ, Teng XD, Fan J. Factors associated with recurrence and therapeutic strategies for sinonasal Rosai-Dorfman disease. Head Neck. 2012;34:1504–13.

    Article  PubMed  Google Scholar 

  57. Duan HG, Zheng CQ, Wang DH, et al. Extranodal sinonasal Rosai-Dorfman disease: a clinical study of 10 cases. Eur Arch Otorhinolaryngol. 2015;272:2313–8.

    Article  PubMed  Google Scholar 

  58. Vujhini SK, Kolte SS, Satarkar RN, Srikanth S. Fine needle aspiration diagnosis of Rosai-Dorfman disease involving thyroid. J Cytol. 2012;29:83–5.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Ma YL, Liang ZP, Xu SE, et al. Rosai-Dorfman disease (RDD) in the paraglottic space: report of a case and review of the literature. Int J Clin Exp Pathol. 2015;8:13532–8.

    PubMed  PubMed Central  Google Scholar 

  60. Wenig BM, Abbondazo SL, Childers EL, Kapadia SB, Heffner DR. Extranodal sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) of the head and neck. Hum Pathol. 1993;24:483–92.

    Article  CAS  PubMed  Google Scholar 

  61. El-Kersh K, Perez RL, Guardiola J. Pulmonary IgG4+ Rosai-Dorfman disease. BMJ Case Rep. 2013;2013:bcr2012008324. doi:10.1136/bcr-2012-008324.

    PubMed  PubMed Central  Google Scholar 

  62. Campana M, Goupil de Bouille J, De Muret A, et al. Pulmonary manifestations revealing Rosai-Dorfman disease. Sarcoidosis Vasc Diffuse Lung Dis. 2015;32:275–7.

    Google Scholar 

  63. Roberts SS, Attanoos RL. IgG4+ Rosai-Dorfman disease of the lung. Histopathology. 2010;56:662–4.

    Article  PubMed  Google Scholar 

  64. Boissiere L, Patey M, Toubas O, et al. Tracheobronchial involvement of Rosai-Dorfman disease. Medicine. 2016;95:1–5.

    Article  Google Scholar 

  65. Pulsoni A, Anghel G, Falcucci P, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol. 2002;69(1):67–71.

    Article  PubMed  Google Scholar 

  66. Ocheni S, Ibegbulam OG, Okafor OC, et al. Usefulness of oral corticosteroids in Rosai-Dorfman disease. Eur J Cancer Care (Engl). 2007;16:286–8.

    Article  CAS  Google Scholar 

  67. O’Gallagher K, Dancy L, Sinha A, Sado D. Rosai-Dorfman disease of the heart. Intractable Rare Dis Res. 2016;5:1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Daruwalla V, Parekh K, Tahir H, Collins JD, Carr J. Extranodal Rosai-Dorfman disease involving the left atrium: cardiac MRI, CT, and PET scan findings. Case Rep Radiol. 2015;2015:753160.

    PubMed  PubMed Central  Google Scholar 

  69. Krishnan A, Nassar A, Nieh P. Rosai-Dorfman disease presenting as extranodal mass. Urology. 2005;66:1317–9.

    Article  Google Scholar 

  70. El Majdoub A, El Houari A, Chbani L, El Fatemi H, Khallouk A, Farih MH. Isolated localization of Rosai-Dorfman disease as renal mass: a case report and review of the literature. Pan Afr Med J. 2016;24(64):1–5.

    Google Scholar 

  71. Sasaki K, Pemmaraju N, Westin JR, et al. A single case of Rosai-Dorman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine. Front Oncol. 2014;297:1–3.

    Google Scholar 

  72. Rocken C, Wieker K, Grote HJ, Muller G, Franke A, Roessner A. Rosai-Dorman disease and generalized AA amyloidosis: a case report. Hum Pathol. 2000;31:621–4.

    Article  CAS  PubMed  Google Scholar 

  73. Harik L, Nassar A. Extranodal Rosai-Dorfman disease of the kidney and coexistent poorly differentiated prostatic adenocarcinoma. Arch Pathol Lab Med. 2006;130:1223–6.

    PubMed  Google Scholar 

  74. Yamada S, Uemura M, Tokumoto M, et al. Hypercalcemia induced by Rosai-Dorfman disease in a hemodialysis patient: histological evidence of Extrarenal Calcitriol overproduction. Intern Med. 2014;53:2783–7.

    Article  PubMed  Google Scholar 

  75. Karaosmanoglu AD, Onur MR, Shirkhoda A, Ozmen M, Hahn PF. Unusual benign solid neoplasms of the kidney: cross-sectional imaging findings. Diagn Interv Radiol. 2015;21:376–81.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Izadyar S, Samiei F, Gholamrezanezhad A. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) – imaging manifestations of renal involvement. Nuclear Med Rev. 2014;17:44–6.

    Article  Google Scholar 

  77. Rodriguez Torres C, Fantova GR, Martinez IE, Castillo Escudero JJ, Arias CDA. Rosai-Dorfman disease with atypical intrascrotal involvement. Int J Urol. 2015;22:794–6.

    Article  PubMed  Google Scholar 

  78. Flores-Carrillo VM, Santaella-Torres F, Sanchez-Martinez LC, et al. Rosai-Dorfman disease presented with involvement of the adrenal gland. A clinical case reported. Rev Med Inst Mex Seguro Soc. 2014;52:224–7.

    PubMed  Google Scholar 

  79. Lauwers GY, Perez-Atayde A, Dorfman RF, Rosai J. The digestive system manifestations of Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy): review of 11 cases. Hum Pathol. 2000;31:380–5.

    Article  CAS  PubMed  Google Scholar 

  80. Baran B, Karaca C, Soyer OM, et al. Rosai-Dorfman disease with diffuse gastrointestinal involvement. Eur J Gastroenterol Hepatol. 2013;25:869–74.

    Article  PubMed  Google Scholar 

  81. Ide M, Asao T, Yoshida T, et al. Rosai-Dorfman disease of the colon presented as small solitary polypoid lesion. Rare Tumors. 2010;31(2):e2.

    Google Scholar 

  82. Hollowood K, Stamp G, Zouvani I, Fletcher CD. Extranodal follicular dendritic cell sarcoma of the gastrointestinal tract. Morphologic, immunohistochemical and ultrastructural analysis of two cases. Am J Clin Pathol. 1995;103:90–7.

    Article  CAS  PubMed  Google Scholar 

  83. Esquivel J, Krishnan J, Jundi M, et al. Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: first case report. Hepatogasroenterol. 1999;46:1202–5.

    CAS  Google Scholar 

  84. Zivin SP, Atieh M, Mosier M, et al. Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: second case report. J Gastrointest Surg. 2009;13:806–9.

    Article  PubMed  Google Scholar 

  85. Podberezin M, Angeles R, Guzman G, Peace D, Gaitonde S. Primary pancreatic sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) an unusual extranodal manifestation clinically simulating malignancy. Arch Pathol Lab Med. 2010;134:276–8.

    PubMed  Google Scholar 

  86. Romero Arenas MA, Singhi AD, Hruban RH, et al. Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy) of the pancreas: third reported occurrence. J Gastrointest Cancer. 2012;43:626–9.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Shaikh F, Awan O, Mohiuddin S, Farooqui S, Kahn SA, McCartney W. 18F-FDG PET /CT imaging of extranodal Rosai-Dorfman disease with hepatopancreatic involvement: a pictorial and literature review. Cureus. 2015;7:e392. doi:10.7759/cureus.392.

    PubMed  PubMed Central  Google Scholar 

  88. Mantilla JG, Goldberg-Stein S, Wang Y. Extranodal Rosai-Dorfman disease. Clinicopathologic series of 10 patients with radiologic correlation and review of the literature. Am J Clin Path. 2016;145:211–21.

    Article  PubMed  Google Scholar 

  89. Melikyan AC, Kovringina AM, Gilyazildinova EA, Gittis MK. A case of sinus histiocytosis with massive lymphadenopathy in a patient with diffuse large cell lymphoma and chronic hepatitis B infection. Ter Arch. 2012;84:66–70.

    CAS  Google Scholar 

  90. Kgomo MK, Elnagar AA, Jeske C, Nagel J. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and cirrhosis of the liver: a case report and literature review. S Afr Med J. 2016;106:463–4.

    Article  Google Scholar 

  91. Di Tommaso L, Rahal D, Bossi P, Roncalli M. Hepatic Rosai-Dorfman disease with coincidental lymphoma: report of a case. Int J Surg Pathol. 2010;18:540–3.

    Article  PubMed  Google Scholar 

  92. Patel MH, Jambhekar KR, Pandey T, Ram R. A rare case of extranodal Rosai-Dorfman disease with isolated multifocal osseous manifestation. Indian J Radiol Imaging. 2015;25:284–7.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Tsang JS, Anthony MP, Wong MP, Wong CS. The use of FDG-PET/CT in extranodal Rosai-Dorfman disease of bone. Skelet Radiol. 2012;41:715–7.

    Article  Google Scholar 

  94. Deshayes E, Le Berre JP, Joanneau E, Vasiljevic A, Raverot G, Seve P. 18F-FDG PET/CT findings in a patient with isolated intracranial Rosai-Dorfman disease. Clin Nucl Med. 2013;38:e50–2.

    Article  PubMed  Google Scholar 

  95. Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT of Rosai-Dorfman disease. Clin Nucl Med. 2015;40:e40–2.

    Article  Google Scholar 

  96. Gupta P, Babyn P. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): a clinicoradiological profile of three cases including two with skeletal disease. Pediatr Radiol. 2008;38:721–8. quiz 821-822

    Article  PubMed  Google Scholar 

  97. Demicco EG, Rosenberg AE, Bjornsson J, et al. Primary Rosai-Dorfman disease of bone: a clinicopathological study of 15 cases. Am J Surg Pathol. 2010;34:1324–33.

    Article  PubMed  Google Scholar 

  98. Paryani NN, Daugherty LC, O’Connor MI, Jiang L. Extranodal Rosai-Dorfman disease of the bone treated with surgery and radiotherapy. Rare Tumors. 2014;6(5531):132–4.

    Article  Google Scholar 

  99. Huang Q, Chang KL, Weiss LM. Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. Am J Surg Pathol. 2006;30:1189–92.

    Article  PubMed  Google Scholar 

  100. Huang BY, Liu HL, Yu CJ. Isolated Intramedullary spinal Rosai-Dorfman disease: a case report and literature review. World Neurosurg. 2016;88:694. e.11-694.e15

    Article  PubMed  Google Scholar 

  101. Oner AY, Akpek S, Tali T. Rosai-Dorfman disease with epidural and spinal bone marrow involvement: magnetic resonance imaging and diffusion-weighted imaging features. Acta Radiol. 2007;48:331–4.

    Article  CAS  PubMed  Google Scholar 

  102. Lima FB, Barcelos PS, Constâncio AP, Nogueira CD, Melo-Filho AA. Rosai-Dorfman disease with spontaneous resolution: case report of a child. Rev Bras Hematol Hemoter. 2011;33:312–4.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Purav P, Ganapathy K, Mallikarjuna VS, et al. Rosai-Dorfman disease of the central nervous system. J Clin Neurosci. 2005;12:656–9.

    Article  CAS  PubMed  Google Scholar 

  104. Forest F, N'guyen AT, Fesselet J, et al. Meningeal Rosai-Dorfman disease mimicking meningioma. Ann Hematol. 2014;93:937–40.

    PubMed  Google Scholar 

  105. Sandoval-Sus JD, Sandoval-Leon AC, Chapman JR, et al. Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature. Medicine (Baltimore). 2014;93:165–75.

    Article  Google Scholar 

  106. Cooper SL, Chavis PS, Fortney JA, Watkins JM, Caplan MJ, Jenrette JM 3rd. A case of orbital Rosai-Dorfman disease responding to radiotherapy. J Pediatr Hematol Oncol. 2008;30:744–8.

    Article  PubMed  Google Scholar 

  107. Maklad AM, Bayoumi Y, Tunio M, Alshakweer W, Dahar MA, Akbar SA. Steroid-resistant extranodal rosai-dorfman disease of cheek mass and ptosis treated with radiation therapy. Case Rep Hematol. 2013;2013:428297. doi:10.1155/2013/428297.

    PubMed  PubMed Central  Google Scholar 

  108. Toguri D, Louie AV, Rizkalla K, Franklin J, Rodrigues G, Venkatesan V. Radiotherapy for steroid-resistant laryngeal Rosai-Dorfman disease. Curr Oncol. 2011;18:e158–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Z'Graggen WJ, Sturzenegger M, Mariani L, Keserue B, Kappeler A, Vajtai I. Isolated Rosai-Dorfman disease of intracranial meninges. Pathol Res Pract. 2006;202:165–70.

    Article  PubMed  Google Scholar 

  110. Shulman S, Katzenstein H, Abramowsky C, Broecker J, Wulkan M, Shehata B. Unusual presentation of Rosai-Dorfman disease (RDD) in the bone in adolescents. Fetal Pediatr Pathol. 2011;30:442–7.

    Article  PubMed  Google Scholar 

  111. McPherson CM, Brown J, Kim AW, DeMonte F. Regression of intracranial rosai-dorfman disease following corticosteroid therapy. Case report. J Neurosurg. 2006;104:840–4.

    Article  PubMed  Google Scholar 

  112. Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S. Diagnosis and management of Rosai-Dorfman disease involving the central nervous system. Neurol Res. 2010;32:572–8.

    Article  PubMed  Google Scholar 

  113. Petrushkin H, Salisbury J, O’Sullivan E. Intralesional steroid for orbital manifestations of Rosai-Dorfman disease. Clin Exp Ophthalmol. 2015;43:483–5.

    Article  PubMed  Google Scholar 

  114. Ottaviano G, Doro D, Marioni G, et al. Extranodal Rosai-Dorfman disease: involvement of eye, nose and trachea. Acta Otolaryngol. 2006;126:657–60.

    Article  PubMed  Google Scholar 

  115. Sakallioglu O, Gok F, Kalman S, et al. Minimal change nephropathy in a 7-year-old boy with Rosai-Dorfman disease. J Nephrol. 2006;19:211–4.

    PubMed  Google Scholar 

  116. Saboo SS, Jagannathan JP, Krajewski KM, et al. Symptomatic extranodal Rosai-Dorfman disease treated with steroids, radiation, and surgery. J Clin Oncol. 2011;29:e772–5.

    Article  CAS  PubMed  Google Scholar 

  117. Horneff G, Jurgens H, Hort W, et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine. Med Pediatr Oncol. 1996;27:187–92.

    Article  CAS  PubMed  Google Scholar 

  118. Scheel MM, Rady PL, Tyring SK, et al. Sinus histiocytosis with massive lymphadenopathy: presentation as giant granuloma annulare and detection of human herpesvirus 6. J Am Acad Dermatol. 1997;37:643–6.

    Article  CAS  PubMed  Google Scholar 

  119. Jabali Y, Smrcka V, Pradna J. Rosai-Dorfman disease: successful long-term results by combination chemotherapy with prednisone, 6-mercaptopurine, methotrexate, and vinblastine: a case report. Int J Surg Pathol. 2005;13:285–9.

    Article  CAS  PubMed  Google Scholar 

  120. Inoue S, Onwuzurike N. Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease. Pediatr Blood Cancer. 2005;45(1):84–5.

    Article  PubMed  Google Scholar 

  121. Arnao V, Riolo M, Savettieri G, Aridon P. Mercaptopurine treatment in an adult man with orbital and intracranial Rosai-Dorfman disease. Case Rep Neurol Med. 2016;2016:1030478. doi:10.1155/2016/1030478. 5 pages

    PubMed  PubMed Central  Google Scholar 

  122. Rivera D, Pérez-Castillo M, Fernández B, Stoeter P. Long-term follow-up in two cases of intracranial Rosai–Dorfman disease complicated by incomplete resection and recurrence. Surg Neurol Int. 2014;5:30. doi:10.4103/2152-7806.128003.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Visser J, Dyer MJ. Refractory, atypical Rosai-dorfman disease successfully treated with a Cytarabine-containing Langerhans cell Histiocytosis treatment regimen-a case report. Pediatr Blood Cancer. 2014;61(11):2142.

    Google Scholar 

  124. Liu P, Wang P, Du J, Zhang J. Successful treatment of refractory cutaneous Rosai-Dorfman disease with vincristine. J Dermatol. 2015;42:97–8.

    Article  CAS  PubMed  Google Scholar 

  125. Nadal M, Kervarrec T, Machet MC, Petrella T, Machet L. Cutaneous Rosai-Dorfman disease located on the breast: rapid effectiveness of methotrexate after failure of topical corticosteroids. Acitretin and thalidomide. Acta Derm Venereol. 2015;95:758–9.

    Article  CAS  PubMed  Google Scholar 

  126. Le Guenno G, Galicier L, Uro-Coste E, et al. Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system. J Neurosurg. 2012;117:486–9.

    Article  PubMed  Google Scholar 

  127. Lohr HF, Godderz W, Wolfe T, et al. Long-term survival in a patient with Rosai-Dorfman disease treated with interferon-alpha. Eur J Cancer. 1995;31A:2427–8.

    Article  CAS  PubMed  Google Scholar 

  128. Le Guenno G, Galicier L, Fieschi C, et al. Dramatic efficiency of pegylated interferon in sinus histiocytosis with massive lymphadenopathy. Br J Dermatol. 2011;164:213–5.

    Article  PubMed  Google Scholar 

  129. Konca C, Ozkurt ZN, Deger M, et al. Extranodal multifocal Rosai–Dorfman disease: response to 2-chlorodeoxyadenosine treatment. Int J Hematol. 2009;89:58–62.

    Article  PubMed  Google Scholar 

  130. Aouba A, Terrier B, Vasiliu V, et al. Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach. Haematologica. 2006;91(12 Suppl):ECR52.

    PubMed  Google Scholar 

  131. Tasso M, Esquembre C, Blanco E, et al. Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine. Pediatr Blood Cancer. 2006;47:612–5.

    Article  CAS  PubMed  Google Scholar 

  132. Simko SJ, Tran HD, Jones J, et al. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer. 2014;61:479–87.

    Article  CAS  PubMed  Google Scholar 

  133. Petschner F, Walker UA, Schmitt-Graff A, et al. “Catastrophic systemic lupus erythematous” with Rosai-Dorfman sinus histiocytosis: successful treatment with anti-CD20/rituximab. Dtsch Med Wochenschr. 2001;126:998–1001.

    Article  CAS  PubMed  Google Scholar 

  134. Pagel JM, Lionberger J, Gopal AK, et al. Therapeutic use of rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). Am J Hematol. 2007;82:1121–2.

    Article  PubMed  Google Scholar 

  135. Appel S, Boehmler AM, Grunebach F, et al. Imatinib mesylate affects the development and function of dendritic cells generated from CD34 peripheral blood progenitor cells. Blood. 2004;103:538–44.

    Article  CAS  PubMed  Google Scholar 

  136. Gebhardt C, Averbeck M, Paasch U, et al. A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy. Arch Dermatol. 2009;145:571–4.

    Article  PubMed  Google Scholar 

  137. Li X, Hong Y, An Q, et al. Successful treatment of Rosai-Dorfman disease with low-dose oral thalidomide. JAMA Dermatol. 2013;149:992–3.

    Article  PubMed  Google Scholar 

  138. Wang F, Zhou H, Luo DQ, Han JD, Chen MK. Dermatoscopic findings in cutaneous Rosai-Dorfman disease and response to low-dose thalidomide. J Dtsch Dermatol Ges. 2014;12:350–2.

    PubMed  Google Scholar 

  139. Chen E, Pavlidakey P, Sami N. Rosai-Dorfman disease successfully treated with thalidomide. JAAD Case Rep. 2016;2:369–72.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Rubinstein M, Assal A, Scherba M, et al. Lenalidomide in the treatment of Rosai Dorfman disease – a first in use report. Am J Hematol. 2016;91:E1. doi:10.1002/ajh.24225.

    Article  PubMed  Google Scholar 

  141. Cooper SL, Arceci RJ, Gamper CJ, Teachey DT, Schafer ES. Successful treatment of recurrent autoimmune cytopenias in the context of sinus histiocytosis with massive lymphadenopathy using sirolimus. Pediatr Blood Cancer. 2016;63:358–60.

    Article  PubMed  Google Scholar 

  142. Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease. Hematology Am Soc Hematol Educ Program. 2015;2015:571–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Hematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada

    Oussama Abla MD

  2. Department of Pathology, University of Pittsburgh School of Medicine, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA, USA

    Jennifer Picarsic MD

Authors
  1. Oussama Abla MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer Picarsic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oussama Abla MD .

Editor information

Editors and Affiliations

  1. University of Toronto, The Hospital for Sick Children, Toronto, Ontario, Canada

    Oussama Abla

  2. Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Hamburg, Germany

    Gritta Janka

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Abla, O., Picarsic, J. (2018). Rosai–Dorfman Disease. In: Abla, O., Janka, G. (eds) Histiocytic Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-59632-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59632-7_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59631-0

  • Online ISBN: 978-3-319-59632-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation